Literature DB >> 30610

Metabolism of methimazole by rat liver cytochrome P-450-containing monoxygenases.

P W Lee, R A Neal.   

Abstract

The incubation of methimazole (1-methyl-2-thioimidazole, MMI) with rat hepatic microsomes led to the formation of 3-methyl-2-thiohydantoin and N-methylimidazole. In addition, an NADPH-stimulated binding of 14C and 35S from [14C]- and [35s]MMI to microsomal macromolecules was seen. Both the NADPH-stimulated N-methylimidazole formation and binding of radioactivity from [14C]- and [35S]MMI to microsomal macromolecules appeared to be catalyzed largely by the cytocrhome P-450 to monoxygenase systems of rat hepatic microsomes. A portion of the radioactivity bound to microsomes incubated with [14C]- and [35S]MMI was released as unchanged MMI on prolonged incubation under acid conditions; this suggests that strong binding of MMI to microsomes occurred. A portion of the 35S bound to microsomes incubated with [35S]MMI can be released as 35SCN- on incubation of the 35S-labeled microsomes with CN-. These data suggest that a portion of the sulfur released in the metabolism of MMI to N-methylimidazole is in the form of atomic sulfur (S), which binds to cysteine sulfhydryl groups (R-S-H) in microsomal proteins to form a hydrodisulfide (R-S-S-H).

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 30610

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  6 in total

Review 1.  An overview on the proposed mechanisms of antithyroid drugs-induced liver injury.

Authors:  Reza Heidari; Hossein Niknahad; Akram Jamshidzadeh; Mohammad Ali Eghbal; Narges Abdoli
Journal:  Adv Pharm Bull       Date:  2015-03-05

2.  The tissue-specific toxicity of methimazole in the mouse olfactory mucosa is partly mediated through target-tissue metabolic activation by CYP2A5.

Authors:  Fang Xie; Xin Zhou; Mary Beth Genter; Melissa Behr; Jun Gu; Xinxin Ding
Journal:  Drug Metab Dispos       Date:  2011-03-17       Impact factor: 3.922

3.  Predicting drug-induced hepatotoxicity using QSAR and toxicogenomics approaches.

Authors:  Yen Low; Takeki Uehara; Yohsuke Minowa; Hiroshi Yamada; Yasuo Ohno; Tetsuro Urushidani; Alexander Sedykh; Eugene Muratov; Viktor Kuz'min; Denis Fourches; Hao Zhu; Ivan Rusyn; Alexander Tropsha
Journal:  Chem Res Toxicol       Date:  2011-07-21       Impact factor: 3.739

Review 4.  Clinical pharmacokinetics of antithyroid drugs.

Authors:  J P Kampmann; J M Hansen
Journal:  Clin Pharmacokinet       Date:  1981 Nov-Dec       Impact factor: 6.447

5.  Reduction of L-methionine selenoxide to seleno-L-methionine by endogenous thiols, ascorbic acid, or methimazole.

Authors:  Renee J Krause; Adnan A Elfarra
Journal:  Biochem Pharmacol       Date:  2008-09-27       Impact factor: 5.858

Review 6.  Factors affecting drug-induced liver injury: antithyroid drugs as instances.

Authors:  Reza Heidari; Hossein Niknahad; Akram Jamshidzadeh; Narges Abdoli
Journal:  Clin Mol Hepatol       Date:  2014-09-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.